CTRR-ncRNA

CTRR-ncRNA catalogs and characterizes non-coding RNAs associated with cancer therapy resistance and recurrence (CTRR) to support identification of biomarkers and mechanistic insights.

Key Features:

• Focused Clinical Characterization: Provides clinical annotation of cancer subtypes, survival outcomes, and responses to personalized therapies for CTRR-associated ncRNAs.
• Biomarker Documentation: Documents ncRNAs that function as biomarkers for personalized prediction and monitoring of therapy resistance and recurrence.
• Preliminary Genotype-Phenotype Analysis: Contains preliminary genotype-phenotype analyses that identify universal ncRNAs as potential CTRR biomarkers.
• Translation-Oriented Resource: Supports mechanistic investigations and explainable artificial intelligence-based modeling for translational research.

Scientific Applications:

• Mechanistic Research: Enables investigation of ncRNA roles in the molecular mechanisms underlying cancer therapy resistance and recurrence.
• Target and Biomarker Discovery: Facilitates identification of novel therapeutic targets and ncRNA biomarkers related to CTRR.
• Predictive Modeling: Supports development of predictive models for personalized treatment strategies, including survival and therapy response prediction.

Methodology:

Compiles curated data on ncRNAs implicated in CTRR and integrates clinical annotations with molecular information to link ncRNA profiles to cancer subtypes, survival outcomes, and therapy response.